1. Home
  2. SII vs TMDX Comparison

SII vs TMDX Comparison

Compare SII & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sprott Inc.

SII

Sprott Inc.

HOLD

Current Price

$106.50

Market Cap

3.0B

Sector

Finance

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$72.00

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SII
TMDX
Founded
2008
1998
Country
Canada
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.6B
IPO Year
2011
2019

Fundamental Metrics

Financial Performance
Metric
SII
TMDX
Price
$106.50
$72.00
Analyst Decision
Strong Buy
Buy
Analyst Count
5
13
Target Price
★ $135.82
$98.73
AVG Volume (30 Days)
86.9K
★ 713.8K
Earning Date
11-04-2026
11-02-2026
Dividend Yield
★ 1.50%
N/A
EPS Growth
N/A
★ 382.18
EPS
N/A
★ 0.61
Revenue
N/A
★ $605,494,000.00
Revenue This Year
$35.89
$22.57
Revenue Next Year
N/A
$17.85
P/E Ratio
★ $63.42
$119.75
Revenue Growth
N/A
★ 37.13
52 Week Low
$78.79
$60.11
52 Week High
$169.63
$156.00

Technical Indicators

Market Signals
Indicator
SII
TMDX
Relative Strength Index (RSI) 31.82 36.32
Support Level $102.24 $66.64
Resistance Level $111.40 $79.60
Average True Range (ATR) 3.41 3.93
MACD -0.83 -0.62
Stochastic Oscillator 17.69 26.43

Price Performance

Historical Comparison
SII
TMDX

About SII Sprott Inc.

Sprott Inc is an alternative asset manager. The company has four reportable segments: Exchange Listed Products, which derives key revenue, and includes management services to the company's closed-end physical trusts and exchange-traded funds, both of which are actively traded on public securities exchanges; Managed equities segment provides asset management and sub-advisory services to the company's branded funds, fixed-term LPs and managed accounts; Private strategies which provide lending and streaming activities through limited partnership vehicles; and the Corporate segment which provides capital, balance sheet management and enterprise shared services to the company's subsidiaries. Geographically, it derives key revenue from Canada, followed by the United States.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: